Yves D.
- Country
- France
- Department
- Neurology
Research Overview
- Randomized Delayed‑Start Trial of Intravenous Ferric Carboxymaltose in Pharmacoresistant Restless Legs Syndrome
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
Data & Insights
Has run more than one trial at 49 of 69 partner sites.
Specializations
Sleep Disorders and Narcolepsy
This investigator specializes in treating various forms of narcolepsy, including both Type 1 with cataplexy and Type 2. Their research encompasses the evaluation of novel therapeutic approaches for managing excessive daytime sleepiness and related symptoms.
- Narcolepsy Type 1 and Type 2 management
- Cataplexy treatment assessment
- Sleep-wake cycle regulation
Hypersomnia and Sleep Regulation
The investigator focuses on treating idiopathic hypersomnia through various therapeutic approaches, including chronobiotherapy. Their work extends to addressing circadian rhythm disorders and sleep-wake cycle disturbances.
- Idiopathic hypersomnia treatment
- Chronotherapeutic interventions
- Sleep cycle optimization
Neurological Sleep Conditions
Their expertise includes treating sleep disorders in patients with cognitive impairment and Alzheimer's disease. The investigator studies the relationship between insomnia and neurological conditions, exploring targeted therapeutic solutions.
- Sleep disorders in neurodegenerative conditions
- Insomnia treatment approaches
- Non-24 Hour Sleep-Wake Disorder management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.